117 related articles for article (PubMed ID: 38832155)
1. The Role of Circulating MicroRNAs in the Prediction of Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer in the Indian Population.
Tripathi S; Mathaiyan J; Kayal S; Nachiappa Ganesh R
Cureus; 2024 May; 16(5):e59553. PubMed ID: 38832155
[TBL] [Abstract][Full Text] [Related]
2. Identification of Differentially Expressed Mirna by Next Generation Sequencing in Locally Advanced Breast Cancer Patients of South Indian Origin.
Tripathi SK; Mathaiyan J; Kayal S; Nachiappa Ganesh R
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2255-2261. PubMed ID: 35901329
[TBL] [Abstract][Full Text] [Related]
3. Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.
Al-Khanbashi M; Caramuta S; Alajmi AM; Al-Haddabi I; Al-Riyami M; Lui WO; Al-Moundhri MS
PLoS One; 2016; 11(4):e0152032. PubMed ID: 27064979
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer.
Zhang Z; Zhang H; Li C; Xiang Q; Xu L; Liu Q; Pang X; Zhang W; Zhang H; Zhang S; Duan X; Liu Y; Cui Y
Thorac Cancer; 2021 Dec; 12(24):3396-3406. PubMed ID: 34751517
[TBL] [Abstract][Full Text] [Related]
5. Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy.
Niwa Y; Yamada S; Sonohara F; Kurimoto K; Hayashi M; Tashiro M; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Kodera Y
J Transl Med; 2019 Jan; 17(1):1. PubMed ID: 30602370
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer.
Raychaudhuri M; Bronger H; Buchner T; Kiechle M; Weichert W; Avril S
Breast Cancer Res Treat; 2017 Apr; 162(3):511-521. PubMed ID: 28181130
[TBL] [Abstract][Full Text] [Related]
7. LncRNA BCAR4 expression predicts the clinical response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Gan FJ; Li Y; Xu MX; Zhou T; Wu S; Hu K; Li Y; Sun SH; Luo Q
Cancer Biomark; 2021; 32(3):339-351. PubMed ID: 34151842
[TBL] [Abstract][Full Text] [Related]
8. Predictive miRNAs Patterns in Blood of Breast Cancer Patients Demonstrating Resistance Towards Neoadjuvant Chemotherapy.
Fan J; Tang Y; Wang K; Yang S; Ma B
Breast Cancer (Dove Med Press); 2023; 15():591-604. PubMed ID: 37593370
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2.
Wang XX; Ye FG; Zhang J; Li JJ; Chen QX; Lin PY; Song CG
Cancer Manag Res; 2018; 10():4393-4400. PubMed ID: 30349372
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression.
Frères P; Josse C; Bovy N; Boukerroucha M; Struman I; Bours V; Jerusalem G
J Cell Physiol; 2015 Feb; 230(2):473-81. PubMed ID: 25078559
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of circulating microRNAs as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer.
Zhu W; Liu M; Fan Y; Ma F; Xu N; Xu B
Cancer Med; 2018 Sep; 7(9):4420-4433. PubMed ID: 30099860
[TBL] [Abstract][Full Text] [Related]
12. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
[TBL] [Abstract][Full Text] [Related]
13. Let-7a-5p, miR-100-5p, miR-101-3p, and miR-199a-3p Hyperexpression as Potential Predictive Biomarkers in Early Breast Cancer Patients.
Fuso P; Di Salvatore M; Santonocito C; Guarino D; Autilio C; Mulè A; Arciuolo D; Rinninella A; Mignone F; Ramundo M; Di Stefano B; Orlandi A; Capoluongo E; Nicolotti N; Franceschini G; Sanchez AM; Tortora G; Scambia G; Barone C; Cassano A
J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442460
[TBL] [Abstract][Full Text] [Related]
14. Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer.
Zou K; Yang E; Cui T; Li Z
Front Oncol; 2022; 12():1036710. PubMed ID: 36439477
[TBL] [Abstract][Full Text] [Related]
15. SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128.
Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992331
[No Abstract] [Full Text] [Related]
16. Novel prognostic and predictive microRNA targets for triple-negative breast cancer.
Turashvili G; Lightbody ED; Tyryshkin K; SenGupta SK; Elliott BE; Madarnas Y; Ghaffari A; Day A; Nicol CJB
FASEB J; 2018 May; ():fj201800120R. PubMed ID: 29812973
[TBL] [Abstract][Full Text] [Related]
17. The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Luo J; Zhou Z; Yang Z; Chen X; Cheng J; Shao Z; Guo X; Tuan J; Fu X; Yu X
Medicine (Baltimore); 2016 Feb; 95(8):e2914. PubMed ID: 26937935
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy.
Yuwen D; Ma Y; Wang D; Gao J; Li X; Xue W; Fan M; Xu Q; Shen Y; Shu Y
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):163-173. PubMed ID: 30228154
[TBL] [Abstract][Full Text] [Related]
20. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
